Bugs Bioscience Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 08911333

		2026		2025
	Notes	£	£	£	£
FIXED ASSETS

CURRENT ASSETS
Debtors	5	82		1,386
Cash at bank and in hand		15,735		30,831

		15,817		32,217
Creditors: Amounts Falling Due Within One Year	6	(600 )		(550 )

NET CURRENT ASSETS (LIABILITIES)			15,217		31,667

TOTAL ASSETS LESS CURRENT LIABILITIES			15,217		31,667

NET ASSETS			15,217		31,667

CAPITAL AND RESERVES
Called up share capital	7		3		3
Share premium account			149,999		149,999
Profit and Loss Account			(134,785 )		(118,335 )

SHAREHOLDERS' FUNDS			15,217		31,667

For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Graham Robert Snudden

Director

14 July 2026

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Bugs Bioscience Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08911333 . The registered office is 2 Royal College Street, London Bioscience Innovation Centre, London, NW1 0NH.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

2.2. Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Office Equipment

2 years straight line

2.4. Cash and Cash Equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.

2.5. Financial Instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities.

2.6. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the profit / loss before taxation.

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2025: NIL)

Page 2

Page 3

Bugs Bioscience Limited

Notes to the Financial Statements (continued)

For The Year Ended 28 February 2026

4. Tangible Assets

	Office Equipment
	£
Cost
As at 1 March 2025	50,659

As at 28 February 2026	50,659

Depreciation
As at 1 March 2025	50,659

As at 28 February 2026	50,659

Net Book Value
As at 28 February 2026	-

As at 1 March 2025	-

5. Debtors

	2026	2025
	£	£
Due within one year
Prepayments and accrued income	-	1,356
VAT	82	30

	82	1,386

6. Creditors: Amounts Falling Due Within One Year

	2026	2025
	£	£
Accruals and deferred income	600	550

7. Share Capital

	2026	2025
Allotted, called up and fully paid	£	£
200,000 Ordinary Shares of £ 0.00001 each	2	2
85,700 Ordinary A shares of £ 0.00001 each	1	1

	3	3

Page 3